Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre R Bonneau

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Biomolecular Screening|June 18, 2011
HTS promiscuity analyses for accelerating decision makingAlexander Böcker, Pierre R Bonneau, Paul J Edwards
Chemmedchem|October 28, 2010
Development of specific "drug-like property" rules for carboxylate-containing oral drug candidatesAlexander Böcker, Pierre R Bonneau, Oliver Hucke, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptasesAlexandre Gagnon, Serge Landry, René Coulombe, et al.
Journal of Molecular Biology|March 15, 2013
Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometryNathalie Goudreau, Oliver Hucke, Anne-Marie Faucher, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
The Conformation of a Peptidyl Methyl Ketone Inhibitor Bound to the Human Cytomegalovirus ProteaseSteven R LaPlante, Dale R Cameron, Norman Aubry, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Araz Jakalian, Steven LaPlante, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptasesAlexandre Gagnon, Ma'an H Amad, Pierre R Bonneau, et al.
Journal of Medicinal Chemistry|August 19, 2005
Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Christiane Yoakim, Pierre R Bonneau, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Biomolecular Screening|June 18, 2011
HTS promiscuity analyses for accelerating decision makingAlexander Böcker, Pierre R Bonneau, Paul J Edwards
Chemmedchem|October 28, 2010
Development of specific "drug-like property" rules for carboxylate-containing oral drug candidatesAlexander Böcker, Pierre R Bonneau, Oliver Hucke, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptasesAlexandre Gagnon, Serge Landry, René Coulombe, et al.
Journal of Molecular Biology|March 15, 2013
Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometryNathalie Goudreau, Oliver Hucke, Anne-Marie Faucher, et al.
Angewandte Chemie (International Ed. in English)|May 2, 2018
The Conformation of a Peptidyl Methyl Ketone Inhibitor Bound to the Human Cytomegalovirus ProteaseSteven R LaPlante, Dale R Cameron, Norman Aubry, et al.
Bioorganic & Medicinal Chemistry Letters|April 25, 2007
Scaffold hopping in the rational design of novel HIV-1 non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Araz Jakalian, Steven LaPlante, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2007
Thiotetrazole alkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptasesAlexandre Gagnon, Ma'an H Amad, Pierre R Bonneau, et al.
Journal of Medicinal Chemistry|August 19, 2005
Novel 8-substituted dipyridodiazepinone inhibitors with a broad-spectrum of activity against HIV-1 strains resistant to non-nucleoside reverse transcriptase inhibitorsJeff A O'Meara, Christiane Yoakim, Pierre R Bonneau, et al.
Pageof 1